Molecules · 2018 · 16 citations · 22 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoverySynthetic Medicinal ChemistryApoptosis PharmacologyOncology PharmacologyAnti-apoptotic AgentsAnticancer ActivityCytochrome C BindingCytotoxicity AssaysMedicinal Chemistry ApplicationsMild Reaction Conditions
Cytisine-pterocarpan derived compounds were biomimetically synthesized with (-)-cytisine and (-)-maackiain via a N,N-4-dimethyl-4-aminopyridine (DMAP)-mediated synthetic strategy in a mild manner. In the present study, tonkinensine B (4) was elaborated in good and high yields with the optimized reaction conditions. The in vitro cytotoxicity of compound 4 was evaluated against breast cancer cell lines and showed that 4 had a better cytotoxicity against MDA-MB-231 cells (IC50 = 19.2 μM). Depending on the research on cytotoxicities of 4 against RAW 264.7 and BV2 cells, it was suggested that 4 produced low cytotoxic effects on the central nervous system. Further study indicated that 4 demonstrated cytotoxic activity against MDA-MB-231 cells and the cytotoxic activity was induced by apoptosis. The results implied that the apoptosis might be induced by mitochondrion-mediated apoptosis via regulating the ratio of Bax/Bcl-2 and promoting the release of cytochrome c from the mitochondrion to the cytoplasm in MDA-MB-231 cells.
22
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology · 2015 · 5.3K citations · Full text
National cancer incidence and mortality in China, 2012.
Wanqing Chen, Rongshou Zheng, Tingting Zuo et al. · PubMed · 2016 · 168 citations
Medicine, Health Sciences, Oncology +12
Thomas A. Engler, Kenneth O. LaTessa, Rajesh Iyengar et al. · Bioorganic & Medicinal Chemistry · 1996 · 100 citations